466 results on '"Jäck, Hans-Martin"'
Search Results
2. Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage
3. Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry
4. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity
5. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
6. Profound neutralization evasion and augmented host cell entry are hallmarks of the fast-spreading SARS-CoV-2 lineage XBB.1.5
7. IRF4 deficiency vulnerates B-cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity
8. Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage
9. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
10. Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
11. Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses
12. No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2
13. Identification of TFG- and Autophagy-Regulated Proteins and Glycerophospholipids in B Cells.
14. The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency
15. Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance
16. Increased risk of chronic fatigue and hair loss following COVID-19 in individuals with hypohidrotic ectodermal dysplasia
17. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks
18. Identification of miR-128 Target mRNAs That Are Expressed in B Cells Using a Modified Dual Luciferase Vector
19. Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3
20. APOBEC3 enzymes restrict marginal zone B cells
21. Unraveling the mysteries of plasma cells
22. miRNA meets plasma cells “How tiny RNAs control antibody responses”
23. BCL6 is critical for the development of a diverse primary B cell repertoire
24. The intestine: A highly dynamic microenvironment for IgA plasma cells
25. Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage
26. Induction of Pre-B Cell Proliferation after de novo Synthesis of the Pre-B Cell Receptor
27. Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
28. The microRNA processing subunit DGCR8 is required for a T cell-dependent germinal center response
29. The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
30. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1
31. Lung cell entry, cell–cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75
32. Essential control of early B-cell development by Mef2 transcription factors
33. Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients
34. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies
35. Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5
36. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
37. BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors
38. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
39. Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
40. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
41. Augmented neutralization of SARS‐CoV‐2 Omicron variant by boost vaccination and monoclonal antibodies
42. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
43. Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production
44. B cell homeostasis and plasma cell homing controlled by Krüppel-like factor 2
45. Single‐cell resolution of plasma cell fate programming in health and disease
46. The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic
47. Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
48. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
49. Early Onset of Autoimmune Disease by the Retroviral Integrase Inhibitor Raltegravir
50. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.